Weight-Loss

Biotech

Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…

Read More »
Biotech

Structure Therapeutics’ Surge in Pre-Market Trading: A Deep Dive

Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…

Read More »
Consumer

ELEVAI Skincare CEO to Present at Beauty Through Science Conference in Stockholm, Sweden

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…

Read More »
Biotech

ELEVAI Biosciences CEO to Showcase Company’s Obesity and Muscle Loss Prevention Technology at UCLA LA-BEST 2024 Conference

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…

Read More »
Featured

ELEVAI Labs: A Strategic Expansion in Biosciences and Skincare

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…

Read More »
Back to top button